TY - JOUR
T1 - Deficiency in endocannabinoid synthase DAGLB contributes to early onset Parkinsonism and murine nigral dopaminergic neuron dysfunction
AU - Liu, Zhenhua
AU - Yang, Nannan
AU - Dong, Jie
AU - Tian, Wotu
AU - Chang, Lisa
AU - Ma, Jinghong
AU - Guo, Jifeng
AU - Tan, Jieqiong
AU - Dong, Ao
AU - He, Kaikai
AU - Zhou, Jingheng
AU - Cinar, Resat
AU - Wu, Junbing
AU - Salinas, Armando G.
AU - Sun, Lixin
AU - Kumar, Mantosh
AU - Sullivan, Breanna T.
AU - Oldham, Braden B.
AU - Pitz, Vanessa
AU - Makarious, Mary B.
AU - Ding, Jinhui
AU - Kung, Justin
AU - Xie, Chengsong
AU - Hawes, Sarah L.
AU - Wang, Lupeng
AU - Wang, Tao
AU - Chan, Piu
AU - Zhang, Zhuohua
AU - Le, Weidong
AU - Chen, Shengdi
AU - Lovinger, David M.
AU - Blauwendraat, Cornelis
AU - Singleton, Andrew B.
AU - Cui, Guohong
AU - Li, Yulong
AU - Cai, Huaibin
AU - Tang, Beisha
N1 - Publisher Copyright:
© 2022, This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.
PY - 2022/6/17
Y1 - 2022/6/17
N2 - Endocannabinoid (eCB), 2-arachidonoyl-glycerol (2-AG), the most abundant eCB in the brain, regulates diverse neural functions. Here we linked multiple homozygous loss-of-function mutations in 2-AG synthase diacylglycerol lipase β (DAGLB) to an early onset autosomal recessive Parkinsonism. DAGLB is the main 2-AG synthase in human and mouse substantia nigra (SN) dopaminergic neurons (DANs). In mice, the SN 2-AG levels were markedly correlated with motor performance during locomotor skill acquisition. Genetic knockdown of Daglb in nigral DANs substantially reduced SN 2-AG levels and impaired locomotor skill learning, particularly the across-session learning. Conversely, pharmacological inhibition of 2-AG degradation increased nigral 2-AG levels, DAN activity and dopamine release and rescued the locomotor skill learning deficits. Together, we demonstrate that DAGLB-deficiency contributes to the pathogenesis of Parkinsonism, reveal the importance of DAGLB-mediated 2-AG biosynthesis in nigral DANs in regulating neuronal activity and dopamine release, and suggest potential benefits of 2-AG augmentation in alleviating Parkinsonism.
AB - Endocannabinoid (eCB), 2-arachidonoyl-glycerol (2-AG), the most abundant eCB in the brain, regulates diverse neural functions. Here we linked multiple homozygous loss-of-function mutations in 2-AG synthase diacylglycerol lipase β (DAGLB) to an early onset autosomal recessive Parkinsonism. DAGLB is the main 2-AG synthase in human and mouse substantia nigra (SN) dopaminergic neurons (DANs). In mice, the SN 2-AG levels were markedly correlated with motor performance during locomotor skill acquisition. Genetic knockdown of Daglb in nigral DANs substantially reduced SN 2-AG levels and impaired locomotor skill learning, particularly the across-session learning. Conversely, pharmacological inhibition of 2-AG degradation increased nigral 2-AG levels, DAN activity and dopamine release and rescued the locomotor skill learning deficits. Together, we demonstrate that DAGLB-deficiency contributes to the pathogenesis of Parkinsonism, reveal the importance of DAGLB-mediated 2-AG biosynthesis in nigral DANs in regulating neuronal activity and dopamine release, and suggest potential benefits of 2-AG augmentation in alleviating Parkinsonism.
KW - Animals
KW - Dopamine/metabolism
KW - Dopaminergic Neurons/metabolism
KW - Endocannabinoids/metabolism
KW - Lipoprotein Lipase/metabolism
KW - Mice
KW - Parkinsonian Disorders/metabolism
KW - Substantia Nigra/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85132346006&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85132346006&partnerID=8YFLogxK
U2 - 10.1038/s41467-022-31168-9
DO - 10.1038/s41467-022-31168-9
M3 - Article
C2 - 35715418
AN - SCOPUS:85132346006
SN - 2041-1723
VL - 13
SP - 3490
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 3490
ER -